SS
NVAX icon

SBI Securities’s Novavax NVAX Stock Holding History

SBI Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
30,645
-952
-3% -$8.53K 0.01% 558
2026
Q1 		$257K Buy
31,597
+188
+0.6% +$1.7K 0.01% 556
2025
Q4 		$211K Sell
31,409
-458
-1% -$3.45K 0.01% 615
2025
Q3 		$276K Sell
31,867
-2,228
-7% -$17.3K 0.01% 544
2025
Q2 		$215K Buy
34,095
+1,766
+5% +$11.7K 0.01% 571
2025
Q1 		$207K Sell
32,329
-2,156
-6% -$17.8K 0.01% 525
2024
Q4 		$277K Buy
+34,485
New +$332K 0.01% 460

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

SBI Securities's NVAX Position: Q2 2026 in Review

SBI Securities reduced its Novavax (NVAX) stake by 3% in Q2 2026, selling an estimated $8.53K and leaving 30,645 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #558.

SBI Securities first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • SBI Securities held 30,645 shares of Novavax worth $289K as of Q2 2026.
  • SBI Securities sold 952 Novavax shares in Q2 2026, an estimated $8.53K.
  • Novavax made up 0.01% of SBI Securities's portfolio in Q2 2026, its #558 holding.
  • SBI Securities first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.